{"transactions":[{"id":3459406,"issuer":{"id":155932,"kind":"organization","name":"Telemynd, Inc.","symbol":"NONE"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-18T18:48:42.000Z","date":"2019-07-16","kind":"other","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd. under which he exchanged previously held securities for shares of Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd. under which he exchanged previously held securities for shares of Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration."}],"balance_after":1000000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001213900-19-013143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000121390019013143/ownership.xml","form_type":"4"}},{"id":3459405,"issuer":{"id":155932,"kind":"organization","name":"Telemynd, Inc.","symbol":"NONE"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T18:48:42.000Z","date":"2019-07-16","kind":"other","acquired":true,"shares":1132925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."}],"balance_after":1132925,"source":{"system":"sec-edgar","filing":"0001213900-19-013143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000121390019013143/ownership.xml","form_type":"4"}},{"id":3514146,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2019-05-23T20:59:44.000Z","date":"2019-05-23","kind":"purchase","acquired":true,"shares":200000,"price":1.254,"value":250800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 15,000 restricted shares that are subject to vesting."}],"balance_after":1117925,"source":{"system":"sec-edgar","filing":"0001615774-19-008336","document":"s118516_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577419008336/s118516_form4.xml","form_type":"4"}},{"id":3596241,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2019-03-15T00:08:56.000Z","date":"2019-03-14","kind":"purchase","acquired":true,"shares":100000,"price":1.676,"value":167600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 15,000 restricted shares that are subject to vesting."}],"balance_after":917925,"source":{"system":"sec-edgar","filing":"0001615774-19-004072","document":"s116731_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577419004072/s116731_form4.xml","form_type":"4"}},{"id":3680310,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-02-01T16:00:40.000Z","date":"2019-01-31","kind":"purchase","acquired":true,"shares":1000000,"price":0.23,"value":230000.0,"ownership":{"direct":true},"balance_after":4781204,"source":{"system":"sec-edgar","filing":"0000905718-19-000094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000090571819000094/ownership.xml","form_type":"4"}},{"id":3694922,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-01-16T16:45:38.000Z","date":"2019-01-14","kind":"purchase","acquired":true,"shares":1000000,"price":0.225,"value":225000.0,"ownership":{"direct":true},"balance_after":3781204,"source":{"system":"sec-edgar","filing":"0000905718-19-000055","document":"cancer_form4jan142019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000090571819000055/cancer_form4jan142019.xml","form_type":"4"}},{"id":3793779,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2018-10-11T00:06:04.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":30000,"price":1.38,"value":41400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The above restricted shares were granted under Mynd Analytics, Inc.'s (the \"Company\") Amended and Restated 2012 Omnibus Incentive Compensation Plan and vest quarterly."}],"balance_after":832925,"source":{"system":"sec-edgar","filing":"0001615774-18-010691","document":"s113208_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010691/s113208_form4.xml","form_type":"4"}},{"id":3808633,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2018-09-26T01:39:07.000Z","date":"2018-09-24","kind":"grant","acquired":true,"shares":135135,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting Person purchased 135,135 units at a price of $1.85 per unit, with each unit consisting of: (i) one share of Common Stock and (ii) one Common Stock Purchase Warrant to purchase one share of Common Stock for $2.00 per share."}],"balance_after":135135,"derivative":{"exercise_price":2,"exercise_date":"2019-03-24","expiration_date":"2023-09-23","underlying":"Common Stock","underlying_shares":135135},"source":{"system":"sec-edgar","filing":"0001615774-18-009968","document":"s112892_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418009968/s112892_form4.xml","form_type":"4"}},{"id":3808632,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-26T01:39:07.000Z","date":"2018-09-24","kind":"grant","acquired":true,"shares":135135,"price":1.85,"value":249999.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"135,135 shares of Common Stock and Warrants to purchase 135,135 shares of Common Stock for $2.00 were purchased by the Reporting Person for an aggregate of $250,000 pursuant to a Subscription Agreement, dated September 21, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto."}],"balance_after":802925,"source":{"system":"sec-edgar","filing":"0001615774-18-009968","document":"s112892_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418009968/s112892_form4.xml","form_type":"4"}},{"id":3832041,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T01:37:02.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":50000,"price":1.63,"value":81500.0,"ownership":{"direct":true},"balance_after":667790,"source":{"system":"sec-edgar","filing":"0001615774-18-008752","document":"s112368_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418008752/s112368_form4a.xml","form_type":"4/A","original_submission_date":"2018-08-28"}},{"id":3832040,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T01:37:02.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":50000,"price":1.62,"value":81000.0,"ownership":{"direct":true},"balance_after":617790,"source":{"system":"sec-edgar","filing":"0001615774-18-008752","document":"s112368_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418008752/s112368_form4a.xml","form_type":"4/A","original_submission_date":"2018-08-28"}},{"id":3832039,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-28T22:45:29.000Z","date":"2018-08-28","kind":"grant","acquired":true,"shares":50000,"price":1.63,"value":81500.0,"ownership":{"direct":true},"balance_after":667790,"source":{"system":"sec-edgar","filing":"0001615774-18-008733","document":"s112361_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418008733/s112361_form4.xml","form_type":"4"}},{"id":3832038,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-28T22:45:29.000Z","date":"2018-08-28","kind":"grant","acquired":true,"shares":50000,"price":1.62,"value":81000.0,"ownership":{"direct":true},"balance_after":617790,"source":{"system":"sec-edgar","filing":"0001615774-18-008733","document":"s112361_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418008733/s112361_form4.xml","form_type":"4"}},{"id":3914651,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-31T00:26:25.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":4500,"price":2.27,"value":10215.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 25, 2018, the Board of Directors (the \"Board\") of MYnd Analytics, Inc. granted the indicated number of restricted shares (the \"Shares\") in lieu of the remaining amount of the Reporting Person's Board fee for the 2017-2018 fiscal year. The Shares were issued pursuant to the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan."}],"balance_after":567790,"source":{"system":"sec-edgar","filing":"0001615774-18-004580","document":"s110525_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418004580/s110525_form4.xml","form_type":"4"}},{"id":3977714,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2018-04-02T23:16:08.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":500000,"price":62500,"value":31250000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person beneficially owns 500,000 shares of Series a Preferred Stock and Warrants to purchase 500,000 shares of Common Stock that were purchased by his spouse, Mary Pappajohn. These shares of Series a Preferred Stock and Warrants were purchased pursuant to the Subscription Agreement, dated as of March 29, 2018. Mr. Pappajohn disclaims beneficial ownership of any shares of Series A Preferred Stock and Warrants held by Mrs. Pappajohn."}],"balance_after":500000,"derivative":{"exercise_price":2.34,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615774-18-002319","document":"s109514_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002319/s109514_form4.xml","form_type":"4"}},{"id":3977713,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2018-04-02T23:16:08.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":500000,"price":62500,"value":31250000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."}],"balance_after":500000,"derivative":{"exercise_price":2.34,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615774-18-002319","document":"s109514_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002319/s109514_form4.xml","form_type":"4"}},{"id":3977712,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-04-02T23:16:08.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":500000,"price":937500,"value":468750000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person beneficially owns 500,000 shares of Series a Preferred Stock and Warrants to purchase 500,000 shares of Common Stock that were purchased by his spouse, Mary Pappajohn. These shares of Series a Preferred Stock and Warrants were purchased pursuant to the Subscription Agreement, dated as of March 29, 2018. Mr. Pappajohn disclaims beneficial ownership of any shares of Series A Preferred Stock and Warrants held by Mrs. Pappajohn."}],"balance_after":500000,"derivative":{"exercise_price":1.875,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615774-18-002319","document":"s109514_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002319/s109514_form4.xml","form_type":"4"}},{"id":3977711,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-04-02T23:16:08.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":500000,"price":937500,"value":468750000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."}],"balance_after":500000,"derivative":{"exercise_price":1.875,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615774-18-002319","document":"s109514_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002319/s109514_form4.xml","form_type":"4"}},{"id":4104681,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-08T23:00:23.000Z","date":"2018-01-05","kind":"purchase","acquired":true,"shares":10000,"price":3.4378,"value":34378.0,"ownership":{"direct":true},"balance_after":563290,"source":{"system":"sec-edgar","filing":"0001615774-18-000188","document":"s108669_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418000188/s108669_form4.xml","form_type":"4"}},{"id":4136997,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-12-11T17:03:29.000Z","date":"2017-12-08","kind":"purchase","acquired":true,"shares":150000,"price":1.86,"value":279000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.842 to $1.862, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":2781204,"source":{"system":"sec-edgar","filing":"0001349929-17-000096","document":"wf-form4_151302979599364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000096/wf-form4_151302979599364.xml","form_type":"4"}},{"id":4198337,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-02T17:11:17.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":5000,"derivative":{"exercise_price":2.75,"exercise_date":"2018-09-28","expiration_date":"2027-09-28","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001349929-17-000085","document":"wf-form4_150697866321552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000085/wf-form4_150697866321552.xml","form_type":"4"}},{"id":4198336,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-10-02T17:11:17.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":2631204,"source":{"system":"sec-edgar","filing":"0001349929-17-000085","document":"wf-form4_150697866321552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000085/wf-form4_150697866321552.xml","form_type":"4"}},{"id":4204430,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-09-21T19:54:48.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments beginning on December 19, 2017."}],"balance_after":12000,"derivative":{"exercise_price":3.6,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615774-17-005238","document":"s107565_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005238/s107565_form4.xml","form_type":"4"}},{"id":4204429,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-21T19:54:48.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":553290,"source":{"system":"sec-edgar","filing":"0001615774-17-005238","document":"s107565_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005238/s107565_form4.xml","form_type":"4"}},{"id":4229959,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-08-18T16:32:37.000Z","date":"2017-08-18","kind":"purchase","acquired":true,"shares":20000,"price":3.278,"value":65560.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The original Form 4, filed on August 18, 2017 is amended to correctly reflect the transaction date.  No other changes have been made to the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2628704,"source":{"system":"sec-edgar","filing":"0001349929-17-000067","document":"wf-form4a_150308834343802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000067/wf-form4a_150308834343802.xml","form_type":"4/A","original_submission_date":"2017-08-18"}},{"id":4229958,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-08-18T16:32:37.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":66185,"price":3.235,"value":214108.475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":2608704,"source":{"system":"sec-edgar","filing":"0001349929-17-000067","document":"wf-form4a_150308834343802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000067/wf-form4a_150308834343802.xml","form_type":"4/A","original_submission_date":"2017-08-18"}},{"id":4229957,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-08-18T16:19:19.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":20000,"price":3.278,"value":65560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2628704,"source":{"system":"sec-edgar","filing":"0001349929-17-000065","document":"wf-form4_150308754502820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000065/wf-form4_150308754502820.xml","form_type":"4"}},{"id":4229956,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-08-18T16:19:19.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":66185,"price":3.235,"value":214108.475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":2608704,"source":{"system":"sec-edgar","filing":"0001349929-17-000065","document":"wf-form4_150308754502820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000065/wf-form4_150308754502820.xml","form_type":"4"}},{"id":4238270,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-10T20:00:42.000Z","date":"2017-08-09","kind":"purchase","acquired":true,"shares":5000,"price":3.3367,"value":16683.5,"ownership":{"direct":true},"balance_after":541290,"source":{"system":"sec-edgar","filing":"0001615774-17-004226","document":"s107135_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417004226/s107135_form4.xml","form_type":"4"}},{"id":4244718,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T22:09:00.000Z","date":"2017-08-02","kind":"purchase","acquired":true,"shares":5000,"price":3.6484,"value":18242.0,"ownership":{"direct":true},"balance_after":536290,"source":{"system":"sec-edgar","filing":"0001615774-17-004052","document":"s107025_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417004052/s107025_form4.xml","form_type":"4"}},{"id":4251459,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-27T00:02:32.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":5000,"price":3.9992,"value":19996.0,"ownership":{"direct":true},"balance_after":531290,"source":{"system":"sec-edgar","filing":"0001615774-17-003843","document":"s106916_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417003843/s106916_form4.xml","form_type":"4"}},{"id":4252248,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-25T21:29:42.000Z","date":"2017-07-21","kind":"purchase","acquired":true,"shares":5000,"price":4.1986,"value":20993.0,"ownership":{"direct":true},"balance_after":526290,"source":{"system":"sec-edgar","filing":"0001615774-17-003801","document":"s106893_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417003801/s106893_form4.xml","form_type":"4"}},{"id":4252247,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-25T21:29:42.000Z","date":"2017-07-21","kind":"purchase","acquired":true,"shares":5000,"price":4.3,"value":21500.0,"ownership":{"direct":true},"balance_after":521290,"source":{"system":"sec-edgar","filing":"0001615774-17-003801","document":"s106893_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417003801/s106893_form4.xml","form_type":"4"}},{"id":4254911,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-19T20:10:22.000Z","date":"2017-07-18","kind":"purchase","acquired":true,"shares":5000,"price":4.5389,"value":22694.5,"ownership":{"direct":true},"balance_after":516290,"source":{"system":"sec-edgar","filing":"0001615774-17-003722","document":"s106856_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417003722/s106856_form4.xml","form_type":"4"}},{"id":4254910,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-19T20:10:22.000Z","date":"2017-07-17","kind":"purchase","acquired":true,"shares":5000,"price":4.4,"value":22000.0,"ownership":{"direct":true},"balance_after":511290,"source":{"system":"sec-edgar","filing":"0001615774-17-003722","document":"s106856_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417003722/s106856_form4.xml","form_type":"4"}},{"id":4286238,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-06-12T16:11:53.000Z","date":"2017-06-12","kind":"purchase","acquired":true,"shares":100000,"price":3.7487,"value":374870.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.575 to $3.80, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":2542519,"source":{"system":"sec-edgar","filing":"0001349929-17-000055","document":"wf-form4_149729829786206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000055/wf-form4_149729829786206.xml","form_type":"4"}},{"id":4288922,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T16:35:33.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":10000,"derivative":{"exercise_price":4.15,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-17-000049","document":"wf-form4_149695411672230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000049/wf-form4_149695411672230.xml","form_type":"4"}},{"id":4288921,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-06-08T16:35:33.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":2442519,"source":{"system":"sec-edgar","filing":"0001349929-17-000049","document":"wf-form4_149695411672230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000049/wf-form4_149695411672230.xml","form_type":"4"}},{"id":4316746,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-05-17T16:26:57.000Z","date":"2017-05-16","kind":"purchase","acquired":true,"shares":19310,"price":3.7969,"value":73318.139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.75 to $3.85, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":2440019,"source":{"system":"sec-edgar","filing":"0001349929-17-000035","document":"wf-form4_149505280305709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992917000035/wf-form4_149505280305709.xml","form_type":"4"}},{"id":4348333,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-04-06","kind":"purchase","acquired":true,"shares":59,"price":0.85,"value":50.15,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1750930,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348332,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-04-05","kind":"purchase","acquired":true,"shares":474,"price":0.85,"value":402.9,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1750871,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348331,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-04-04","kind":"purchase","acquired":true,"shares":12125,"price":0.85,"value":10306.25,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1750397,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348330,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":3186,"price":0.7494,"value":2387.5884,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1738272,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348329,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-23","kind":"purchase","acquired":true,"shares":4300,"price":0.75,"value":3225.0,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1735086,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348328,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-22","kind":"purchase","acquired":true,"shares":20077,"price":0.7496,"value":15049.7192,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1730786,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348327,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":1400,"price":0.7476,"value":1046.64,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1710709,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348326,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-16","kind":"purchase","acquired":true,"shares":700,"price":0.75,"value":525.0,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1709309,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348325,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-15","kind":"purchase","acquired":true,"shares":336,"price":0.75,"value":252.0,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1708609,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348324,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-14","kind":"purchase","acquired":true,"shares":15852,"price":0.7441,"value":11795.4732,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":1708273,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4348323,"issuer":{"id":161766,"kind":"organization","name":"HOOPER HOLMES INC","symbol":"HPHW"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T17:19:15.000Z","date":"2017-03-09","kind":"purchase","acquired":true,"shares":100000,"price":0.7266,"value":72660.0,"ownership":{"direct":true},"balance_after":1692421,"source":{"system":"sec-edgar","filing":"0001615774-17-001821","document":"s105933_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/741815/000161577417001821/s105933_form4.xml","form_type":"4"}},{"id":4357269,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-07T01:27:21.000Z","date":"2017-04-03","kind":"purchase","acquired":true,"shares":9878,"price":6.4632,"value":63843.4896,"ownership":{"direct":true},"balance_after":506290,"source":{"system":"sec-edgar","filing":"0001615774-17-001542","document":"s105823_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417001542/s105823_form4.xml","form_type":"4"}},{"id":4375530,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-22T22:49:19.000Z","date":"2017-03-21","kind":"grant","acquired":true,"shares":40000,"price":6.25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."}],"balance_after":496412,"source":{"system":"sec-edgar","filing":"0001615774-17-001186","document":"s105635_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417001186/s105635_form4.xml","form_type":"4"}},{"id":4451580,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T21:01:55.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":32000,"price":6.25,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."}],"balance_after":456412,"source":{"system":"sec-edgar","filing":"0001615774-17-000591","document":"s105338_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417000591/s105338_form4.xml","form_type":"4"}},{"id":4510081,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-30T22:47:18.000Z","date":"2016-12-29","kind":"grant","acquired":true,"shares":16000,"price":6.25,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."}],"balance_after":424412,"source":{"system":"sec-edgar","filing":"0001615774-16-009121","document":"s105051_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416009121/s105051_form4.xml","form_type":"4"}},{"id":4536138,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T21:36:20.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":32000,"price":6.25,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."}],"balance_after":408412,"source":{"system":"sec-edgar","filing":"0001615774-16-008687","document":"s104848_johnpappajohn.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416008687/s104848_johnpappajohn.xml","form_type":"4"}},{"id":4540408,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-11-29T17:13:24.000Z","date":"2016-11-28","kind":"purchase","acquired":true,"shares":100000,"price":1.4528,"value":145280.0,"ownership":{"direct":true},"balance_after":2420709,"source":{"system":"sec-edgar","filing":"0001349929-16-000134","document":"wf-form4_148045759216252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992916000134/wf-form4_148045759216252.xml","form_type":"4"}},{"id":4553616,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-11-16T16:06:06.000Z","date":"2016-11-14","kind":"purchase","acquired":true,"shares":31100,"price":1.4807,"value":46049.77,"ownership":{"direct":true},"balance_after":2320709,"source":{"system":"sec-edgar","filing":"0001349929-16-000128","document":"wf-form4_147933035263436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992916000128/wf-form4_147933035263436.xml","form_type":"4"}},{"id":4570147,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T01:49:43.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The award was recommended by the compensation committee and approved by the board of directors of MYnd Analytics, Inc. (the \"Registrant\") on September 22, 2016, subject to stockholder approval of the Amended and Restated 2012 Omnibus Incentive Compensation Plan (the \"Plan\") under which the award was granted. The Registrant's stockholders approved the Plan on November 1, 2016."}],"balance_after":376412,"source":{"system":"sec-edgar","filing":"0001615774-16-007992","document":"s104519_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007992/s104519_form4.xml","form_type":"4"}},{"id":4575847,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-24T20:35:22.000Z","date":"2016-10-20","kind":"purchase","acquired":true,"shares":200,"price":8.5,"value":1700.0,"ownership":{"direct":true},"balance_after":356412,"source":{"system":"sec-edgar","filing":"0001615774-16-007718","document":"s104379_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007718/s104379_form4.xml","form_type":"4"}},{"id":4577871,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-19T20:30:38.000Z","date":"2016-10-17","kind":"purchase","acquired":true,"shares":1000,"price":8,"value":8000.0,"ownership":{"direct":true},"balance_after":356212,"source":{"system":"sec-edgar","filing":"0001615774-16-007679","document":"s104359_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007679/s104359_form4.xml","form_type":"4"}},{"id":4579849,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T20:30:36.000Z","date":"2016-10-12","kind":"purchase","acquired":true,"shares":16,"price":7.5,"value":120.0,"ownership":{"direct":true},"balance_after":355212,"source":{"system":"sec-edgar","filing":"0001615774-16-007625","document":"s104336_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007625/s104336_form4.xml","form_type":"4"}},{"id":4580406,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-13T16:28:43.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":10000,"derivative":{"exercise_price":1.81,"exercise_date":"2017-10-11","expiration_date":"2026-10-11","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-16-000116","document":"wf-form4_147639051105560.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992916000116/wf-form4_147639051105560.xml","form_type":"4"}},{"id":4580405,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-10-13T16:28:43.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":2289609,"source":{"system":"sec-edgar","filing":"0001349929-16-000116","document":"wf-form4_147639051105560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897464/000134992916000116/wf-form4_147639051105560.xml","form_type":"4"}},{"id":4580971,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-12T20:09:19.000Z","date":"2016-10-10","kind":"purchase","acquired":true,"shares":1839,"price":6.4527,"value":11866.5153,"ownership":{"direct":true},"balance_after":355196,"source":{"system":"sec-edgar","filing":"0001615774-16-007600","document":"s104325_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007600/s104325_form4.xml","form_type":"4"}},{"id":4596870,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2016-09-23T22:25:10.000Z","date":"2016-09-21","kind":"disposition_to_issuer","acquired":false,"reported_value":1400000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Stock Warrants were exercisable as of their respective dates of issuance."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001615774-16-007362","document":"s104194_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007362/s104194_form4.xml","form_type":"4"}},{"id":4596869,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"5% Secured Convertible Note due December 2017","published_at":"2016-09-23T22:25:10.000Z","date":"2016-09-21","kind":"exercise","acquired":false,"reported_value":1400000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"Seven notes in the aggregate principal amount of $1,400,000 were purchased by the Reporting Person between September 22, 2014 and August 9, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $1,400,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $52,486.98, at a conversion price of $5.00 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Seven notes in the aggregate principal amount of $1,400,000 were purchased by the Reporting Person between September 22, 2014 and August 9, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $1,400,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $52,486.98, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Seven notes in the aggregate principal amount of $1,400,000 were purchased by the Reporting Person between September 22, 2014 and August 9, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $1,400,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $52,486.98, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Seven notes in the aggregate principal amount of $1,400,000 were purchased by the Reporting Person between September 22, 2014 and August 9, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $1,400,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $52,486.98, at a conversion price of $5.00 per share of common stock."}],"derivative":{"exercise_price":5,"exercise_date":"2016-09-01","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":290498},"source":{"system":"sec-edgar","filing":"0001615774-16-007362","document":"s104194_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007362/s104194_form4.xml","form_type":"4"}},{"id":4596868,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T22:25:10.000Z","date":"2016-09-21","kind":"exercise","acquired":true,"shares":290498,"price":5,"value":1452490.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."}],"balance_after":353357,"source":{"system":"sec-edgar","filing":"0001615774-16-007362","document":"s104194_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007362/s104194_form4.xml","form_type":"4"}},{"id":4599426,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155952,"kind":"person","name":"PAPPAJOHN JOHN","position":1,"cik":"0000897464","reported_name":"PAPPAJOHN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-21T00:24:10.000Z","date":"2016-09-16","kind":"gift","acquired":false,"shares":6538258,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12571699,"source":{"system":"sec-edgar","filing":"0001615774-16-007288","document":"s104171_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007288/s104171_form4.xml","form_type":"4"}}]}